5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | NEUTRAL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.40▲ | 2.41▲ | 2.41▲ | 2.39▲ | 2.43▼ |
MA10 | 2.41▲ | 2.40▲ | 2.40▲ | 2.39▲ | 2.88▼ |
MA20 | 2.39▲ | 2.40▲ | 2.41▲ | 2.42▲ | 3.47▼ |
MA50 | 2.44▼ | 2.42▲ | 2.44▼ | 2.98▼ | 3.56▼ |
MA100 | 2.47▼ | 2.67▼ | 2.77▼ | 3.67▼ | 5.80▼ |
MA200 | 2.94▼ | 3.15▼ | 3.09▼ | 3.71▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.005▲ | 0.006▲ | 0.007▲ | 0.038▲ | -0.118▼ |
RSI | 50.611▲ | 50.041▲ | 49.511▼ | 43.934▼ | 41.482▼ |
STOCH | 58.350 | 69.540 | 69.540 | 52.285 | 15.424▼ |
WILL %R | -24.138▲ | -24.138▲ | -24.138▲ | -32.500 | -79.923▼ |
CCI | 28.510 | 53.751 | 53.094 | 45.271 | -88.314 |
Thursday, July 25, 2024 06:57 AM
ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of inflammatory and renal diseases, ...
|
Thursday, July 18, 2024 10:02 AM
The Nasdaq composite has historically had a high correlation with the S&P 500. The two indexes even share common components, including Apple, Microsoft and Alphabet. Like the S&P 500, the Nasdaq ...
|
Wednesday, July 17, 2024 09:54 AM
The Nasdaq composite has historically had a high correlation with the S&P 500. The two indexes even share common components, including Apple, Microsoft and Alphabet. Like the S&P 500, the Nasdaq ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
26/07/24 | 2.42 | 2.42 | 2.42 | 2.42 | 11,241 |
25/07/24 | 2.40 | 2.4699 | 2.34 | 2.34 | 38,921 |
24/07/24 | 2.35 | 2.47 | 2.35 | 2.43 | 20,880 |
23/07/24 | 2.28 | 2.47 | 2.22 | 2.42 | 48,573 |
22/07/24 | 2.36 | 2.3792 | 2.25 | 2.34 | 37,917 |
19/07/24 | 2.33 | 2.40 | 2.33 | 2.33 | 14,721 |
18/07/24 | 2.47 | 2.47 | 2.355 | 2.37 | 43,280 |
17/07/24 | 2.46 | 2.5232 | 2.35 | 2.38 | 31,702 |
16/07/24 | 2.40 | 2.55 | 2.40 | 2.50 | 95,777 |
15/07/24 | 2.41 | 2.49 | 2.31 | 2.39 | 104,007 |
|
|
||||
|
|
||||
|
|